Differences in biotransformation of raloxifen, tamoxifen and tamoxifen metabolites in Ishikawa human endometrial and MCF7 human breast cancer cell lines

被引：0
|
作者：
Wilborn, Teresa [1 ]
Cretton-Scott, Erika [1 ]
Coward, Lori [2 ]
Gorman, Gregory [2 ]
Falany, Charles N. [3 ]
机构：
[1] Samford Univ, Dept Pharmaceut Social & Adm Sci, McWhorter Sch Pharm, Birmingham, AL USA
[2] Samford Univ, Pharmaceut Sci Res Inst, McWhorter Sch Pharm, Birmingham, AL USA
[3] Univ Alabama, Birmingham, AL USA
来源：
DRUG METABOLISM REVIEWS | 2011年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [1] The Combinatory Effects of Glabridin and Tamoxifen on Ishikawa and MCF-7 Cell Lines
    Jen, Soe Hui
    Wei, Melissa Poh Su
    Yin, Adeline Chia Yoke
    NATURAL PRODUCT COMMUNICATIONS, 2015, 10 (09) : 1573 - 1576
  • [2] Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells
    Chang, Yung-Chieh
    Cheung, Chun Hei Antonio
    Kuo, Yao-Lung
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [3] Biotransformation of tamoxifen in a human endometrial explant culture model
    Sharma, M
    Sharma, M
    Lewis, J
    McGarrigle, BP
    Shubert, DE
    Bofinger, DP
    Olson, JR
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 148 - 148
  • [4] Biotransformation of tamoxifen in a human endometrial explant culture model
    Sharma, M
    Shubert, DE
    Sharma, M
    Lewis, J
    McGarrigle, BP
    Bofinger, DP
    Olson, JR
    CHEMICO-BIOLOGICAL INTERACTIONS, 2003, 146 (03) : 237 - 249
  • [5] Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines
    Azab, SS
    El-Demerdash, E
    Abdel-Naim, AB
    Youssef, E
    El-Sharkawy, N
    Osman, AMM
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (05) : 725 - 732
  • [6] Caveolin expression in tamoxifen-sensitive MCF-7 breast cancer cell lines
    Thomas, NPB
    Hutcheson, IR
    Barrow, D
    Dutkowski, CM
    Campbell, L
    Gumbleton, M
    Nicholson, RI
    BRITISH JOURNAL OF CANCER, 2001, 85 : 99 - 99
  • [7] Inducible upregulation of oestrogen receptor-β1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells
    Murphy, LC
    Peng, B
    Lewis, A
    Davie, JR
    Leygue, E
    Kemp, A
    Ung, K
    Vendetti, M
    Shiu, R
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2005, 34 (02) : 553 - 566
  • [8] ESTROGENIC EFFECT OF TAMOXIFEN AND ITS DERIVATIVES ON THE PROLIFERATION OF MCF7 HUMAN-BREAST TUMOR-CELLS
    SONNENSCHEIN, C
    PAPENDORP, JT
    SOTO, AM
    LIFE SCIENCES, 1985, 37 (04) : 387 - 394
  • [9] TAMOXIFEN ENHANCES CELL-DEATH IN IMPLANTED MCF7 BREAST-CANCER BY INHIBITING ENDOTHELIUM GROWTH
    HARAN, EF
    MARETZEK, AF
    GOLDBERG, I
    HOROWITZ, A
    DEGANI, H
    CANCER RESEARCH, 1994, 54 (21) : 5511 - 5514
  • [10] Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen
    Seeger, H
    Huober, J
    Wallweiner, D
    Mueck, AO
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (05) : 277 - 280
12345